Polymorphism and pseudopolymorphism of acyclovir

Archives of Pharmacal Research

Volumn 31, Issue 2, 2008, Pages 231-234

  Sohn, Young Taek ^a   Kim, Sang Hee ^a  

^a Duksung Women's University   (South Korea)

Author keywords

Acyclovir; DSC; Polymorphism; Pseudopolymorphism; PXRD; TGA

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; SOLVENT;

ARTICLE; CHEMISTRY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; ISOMERISM; SOLUBILITY; THERMOGRAVIMETRY; X RAY DIFFRACTION;

ACYCLOVIR; ANTIVIRAL AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; ISOMERISM; SOLUBILITY; SOLVENTS; THERMOGRAVIMETRY; X-RAY DIFFRACTION;

EID: 42949156919     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-1146-x     Document Type: Article

References (13)

1. Balfour, H. H., Drug therapy: Antiviral drugs, Review. N. Engl. J. Med., 340, 1255-1268 (1999).
2. Giron, D., Thermal analysis and calorimetric methods in the characterization of polymorphs and solvates. Thermochim. Acta, 248, 1-59 (1995).
3. Grünenberg, A., Polymorphie und thermische Analyse pharmazeutischer Wirkstoffe. Pharmazie in unserer Zeit, 26, 224-231 (1997).
4. Haleblian, J. K., Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J. Pharm. Sci., 64, 1269-1288 (1975).
5. Haleblian, J. K. and McCrone, W. C., Pharmaceutical applications of polymorphism. J. Pharm. Sci., 58, 911-929 (1969).
6. Higuchi, W. I., Lau, P. K., Higuchi, T., and Shell, J. W., Polymorphism and drug availability, solubility relations in the methylprednisolone system. J. Pharm. Sci., 52, 150-153 (1963).
7. Hüttenrauch, R., Fundamentals of Pharmaceutics. Acta Pharm. Technol., 34, 1-10 (1988).
8. Kristl, A., Srcic, S., Vrecer, F., Sustar, B., and Vojnovic, D., Polymorphism and pseudopolymorphism: influencing the dissolution properties of the guanine derivative acyclovir. Int. J. Pharm., 139, 231-235 (1996).
9. Kuhnert-Brandstätter, M., Polymorphie von Arzneistoffen und ihre Bedeutung in der pharmazeutischen Technologie. Informationsdienst A.P.V., 19, 73-90 (1973).
10. Kuhnert-Brandstätter, M. and Lehner, G., Differentialthermoanalyse und IR-spektroskopische Untersucungen von Arzneistoffen, die als Hydrate vorliegen. Sci. Pharm., 52, 267-279 (1984).
11. Shefter, E. and Higuchi, T., Dissolution behavior of crystalline solvated and nonsolvated forms of some pharmaceuticals. J. Pharm. Sci., 52, 781-791 (1963).
12. Sohn, Y. T., Effect of crystal form on bioavailability. J. Kor. Pharm. Sci., 34, 443-452 (2004).
13. Zupancic, V., Ograjsek, N., Kotar-Jordan, B. and Vrecer, F., Physical characterization of pantoprazole sodium hydrates. Int. J. Pharm., 291, 59-68 (2005).